PolTREG appoints Dan Shelly as Chief Business Development Officer
21 févr. 2024 01h00 HE
|
PolTREG S.A.
Gdańsk, Poland – 21 February 2024 – PolTREG S.A. (Warsaw Stock Exchange: PTG), a clinical-stage biotechnology company developing cell therapies for a wide range of autoimmune...
PolTREG receives US Patent Office Notice of Allowance for Treg cell therapy to treat Type-1 Diabetes
16 janv. 2024 01h00 HE
|
PolTREG S.A.
Gdańsk, Poland – 16 January 2024, 07:00 CET – PolTREG S.A. (Warsaw Stock Exchange: PTG), a clinical-stage biotechnology company in Europe developing cell therapies for use in a wide...
Regenerative Medicine Market Set to Hit USD 194.9 Billion by 2032, Driven by Robust CAGR of 19.4%
08 janv. 2024 07h35 HE
|
Market.Us
New York, Jan. 08, 2024 (GLOBE NEWSWIRE) -- According to the market.us, the anticipated value of the Global Regenerative Medicine Market is projected to reach approximately USD 194.9 billion by the...
Cell Therapy Technologies Market to reach USD 36 billion in 2031, expanding at a CAGR of 10.5%: TMR Report
19 juin 2023 10h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, June 19, 2023 (GLOBE NEWSWIRE) -- In 2022, the global cell therapy technologies market was estimated to be worth $14.9 billion USD. It is expected to grow at a...
Outpace Bio to Present New Data on OutSmart™ IL-2/15, a CAR T Cell-Produced Designed Cytokine with Tumor-Localized Immune Cell Activity, at the 2023 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
18 mai 2023 08h00 HE
|
Outpace Bio
Seattle, WA, May 18, 2023 (GLOBE NEWSWIRE) -- Outpace Bio, a company using protein design and cell engineering to create advanced cell therapies with curative potential, today announced it will...
Outpace Bio, a Leader in Protein Design for Cell Therapy, Announces Presentation at the 2023 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
09 mai 2023 09h00 HE
|
Outpace Bio
Seattle, WA, May 09, 2023 (GLOBE NEWSWIRE) -- Outpace Bio, a company using protein design and cell engineering to create advanced cell therapies with curative potential, today announced that an...
Outpace Bio, a Leader in Protein Design for Cell Therapy, Strengthens Executive Leadership Team with Key Appointments
04 mai 2023 08h00 HE
|
Outpace Bio
Seattle, WA, May 04, 2023 (GLOBE NEWSWIRE) -- Outpace Bio, a company using protein design and cell engineering to create advanced cell therapies, today announced two key leadership appointments....
The cell therapy manufacturing market is anticipated to grow at an annualized rate of over 12%, claims Roots Analysis
22 nov. 2022 09h00 HE
|
Roots Analysis
London, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Cell Therapy Manufacturing Market (5th Edition), 2022-2035” report to its list of offerings. Owing to the...
NorthX Biologics expanderar till cellterapi: Partnerskap med Alder Therapeutics och ny tillverkningsanläggning på Karolinska campus i Stockholm
21 juin 2022 02h00 HE
|
NorthX Biologics Matfors AB
MATFORS, Sweden, June 21, 2022 (GLOBE NEWSWIRE) -- NorthX Biologics (“NorthX”) har meddelat att de utöver att utöka sin tillverkning av cellterapier vid sin befintliga GMP-anläggning, även...
NorthX Biologics expands to Cell Therapy: Partnership with Alder Therapeutics and new manufacturing site on Karolinska campus
21 juin 2022 02h00 HE
|
NorthX Biologics Matfors AB
MATFORS, Sweden, June 21, 2022 (GLOBE NEWSWIRE) -- Sweden-based NorthX Biologics (“NorthX”) is expanding into cell therapy manufacturing at its existing GMP-facility, as well as in premises at the...